Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

The American, Walter James Palmer, a Minnesota dentist who paid $50,000 to kill the lion, has left Zimbabwe. He says he did kill the animal but believed the hunt was legal and that the necessary permits had been issued. Local hunter Theo Bronkhorst appeared in a courthouse in Hwange, 800 km (500 miles) west of Harare, and was charged with “failing to supervise, control and take reasonable steps to prevent an unlawful hunt”. He pleaded not guilty to the charge and was set free after posting $1,000 bail and depositing his passport with the court. He will return to court on Aug. 5 for trial. Game park owner Honest Ndlovu, who is also accused of assisting Palmer, was not charged on Wednesday and parks officials said he would first testify for the state and be charged later. While Bronkhorst appeared in court in Zimbabwe, Palmer, who is accused of killing Cecil with a bow and arrow, was being pilloried on the Internet, with many people wishing him dead. “This is disgusting. I hope you get thrown in a cage with hungry lions,” Julie Lu wrote on the Facebook page of his dental practice. Palmer said on Tuesday he had hired professional guides who secured hunting permits and deeply regretted taking the lion. He added that he had not been contacted by authorities in Zimbabwe or the United States and would assist in any inquiries. The Zimbabwe police and government have not commented. If found guilty, Bronkhorst could be fined $20,000 and possibly jailed for up to 10 years. The U.S. Fish and Wildlife Service expressed its concern about the killing. “We are currently gathering facts about the issue and will assist Zimbabwe officials in whatever manner requested,” said Vanessa Kauffman, a spokeswoman for the government agency. “It is up to all of us - not just the people of Africa - to ensure that healthy, wild populations of animals continue to roam the savanna for generations to come.”  Cecil was fitted with a GPS collar for a research project by scientists from Oxford University and was one of the oldest and most famous lions in Zimbabwe. The British university’s Wildlife Conservation Research Unit said it had been tracking Cecil since 2008 and was “deeply saddened” by his death. “Insofar as this happened illegally we consider it deeply reprehensible,” it said in a statement. It was working closely with Zimbabwe’s National Parks authorities to support their “meticulous work” in prosecuting the case. The unit also said Cecil’s death would be likely to trigger a power struggle in the pride, resulting in the death of other male lions as well as Cecil’s offspring. “When a male lion is killed, because of the way their society works, a likely consequence is the overthrow and death of other adult male members of his weakened coalition, and the subsequent infanticide of his cubs,” it said. Palmer’s hunting has attracted scrutiny in the past. In 2008, he pleaded guilty to lying to a U.S. wildlife agent about a black bear he killed in Wisconsin two years before. He was accused of killing it 40 miles outside a permitted zone, hauling the carcass back into the approved area and certifying falsely that it was killed there. He was  sentenced to one year probation and fined $2,938. In the Hwange case, Zimbabwe Conservation Task Force chairman Johnny Rodrigues said Cecil was lured out of the park with bait before being shot. The incident has triggered fierce debate over the commercial ‘trophy’ hunting of African big game. Like many countries, Zimbabwe issues annual permits that allow foreign hunters to kill wildlife such as elephant, buffalo and lion legally, arguing that the funds raised allow the government to fund conservation efforts. “Sustainable trophy hunting is part of well-managed wildlife conservation. It creates incentives for people to look after wildlife,” said Adri Kitshoff, chief executive of the Professional Hunters’ Association of South Africa. “It’s easy to fall into the trap of emotions and not focus on facts.”  However, Edward Bourke, chairman of the Australia-based Saving The Lion Foundation, said Cecil’s death showed the dangers of legal hunting. “There is enough global pressure to push for change. There is an opportunity to offer alternatives, including international aid for establishing safe haven environments like national parks or eco-tourism zones,” he said. One of the few countries to avoid Cecil hysteria was Zimbabwe, where most people are more preoccupied with putting food on the table and finding work in an economy suffering 80 percent unemployment. To the state-run Herald newspaper, the most remarkable aspect of the case was the lion’s name, which it linked to British imperialist Cecil Rhodes, after whom the former Rhodesia named. “How someone thought it such a good idea to christen a lion after the infamous plunderer and murderer who roamed dangerously across Africa can only be a matter of conjecture,” it said in an editorial.
Zimbabwean charged over killing of Cecil the lion.

The release does not mention cost or whether it’s covered by private insurance or Medicare, and in this case, it’s a pretty big omission. This may be an enormously expensive treatment for patients — and it’s why we have a cost criterion in our reviews. The hopeful psoriasis patient who sees this release without a cost discussion might already have their hand on the phone to call their dermatologist. Here’s a very rough estimate of what that patient might face in terms of cost: Based on a conservative wholesale price of roughly $4,000 per 80 mg injection and following the recommendation (found on the package insert) of two injections every two weeks for 12 weeks, followed by monthly injections, we calculated $48,000 for the first 12 weeks plus $36,000 for the following 9 months or $84,000 total. The release stated that by week 12, “76.4 to 81.8 percent of patients had their psoriasis classified as “clear” or “minimal” compared to 3.2% of patients on the placebo. By the 60th week, 68.7 to 78.3 percent of patients had maintained their improvement.” We also wanted more detail on the measured strength of the response for each patient. For example, what constitutes “minimal”? The release adequately addresses harms and notes that long-term side effects are unknown with this sentence: “Adverse events associated with ixekizumab included slightly higher rates of neutropenia (low white blood cell count), yeast infection and inflammatory bowel disease compared to the placebo. The safety of therapy longer than 60 weeks will need to be monitored in the future.” The release clearly and thoroughly describes the three phase 3 international trials at 21 sites, that they enrolled a large number of patients, and that they were randomized and controlled. There was no disease mongering. The release describes what psoriasis is and its prevalence, and explains that these trials were for moderate to severe psoriasis which covers at least 10 percent of the body. The release is very transparent in stating that the drug manufacturer paid for the research and that the lead researcher is a paid consultant to Eli Lilly. The release did not compare the many different ways that patients treat psoriasis, some with topical agents and some with oral steroids or other medications. The release states that the drug has been approved by the FDA following the completion of the trials. This is a strong indication that the drug is or soon will be available. The release should have noted that the drug is already being marketed under the brand name Taltz. The release makes an understated claim to novelty with this quote from the lead researcher: “Ten years ago, we thought complete clearance of this disease was impossible. It wasn’t something we would even try to do. Now with this drug, we’re obtaining response levels higher than ever seen before.” There was no unjustifiable language in the release.
New drug clears psoriasis in clinical trials

The Illinois Department of Public Health the adult patient was hospitalized after falling ill following vaping, though it didn’t give other information about the person, including the patient’s name, age, hometown or date of death. The state received the report of the death Thursday, said Dr. Jennifer Layden, the Illinois agency’s chief medical officer. Officials with the Centers for Disease Control and Prevention said Friday that 193 people in 22 states have contracted severe respiratory illnesses after vaping. However, they said a clear-cut common cause of the illnesses hasn’t been identified and that they are being called “potential cases” that are still under investigation. All of the sickened have been teens or adults who had used an electronic cigarette or some other kind of vaping device. Doctors say the illnesses resemble an inhalation injury, with the lungs apparently reacting to a caustic substance. So far, infectious diseases have been ruled out. The illnesses have been reported since late June, but the total count has risen quickly in the past week. That may be partly because cases that weren’t initially being linked to vaping have begun to be grouped that way. Among the newest reports are two in Connecticut, four in Iowa and six in Ohio. Health officials are asking doctors and hospitals to tell state health officials about any possible vaping-related lung disease cases they encounter. In its news release, the Illinois agency said the number of people who contracted a respiratory illness after vaping had doubled in the past week, to 22. “The severity of illness people are experiencing is alarming and we must get the word out that using e-cigarettes and vaping can be dangerous,” IDPH Director Dr. Ngozi Ezike said in the release. Electronic cigarettes have been described as a less dangerous alternative to regular cigarettes, but health officials have been worried about kids using them. Most of the concern has focused on nicotine, which health officials say is harmful to developing brains and might make kids more likely to take up cigarettes. But some vaping products have been found to contain other potentially harmful substances, including flavoring chemicals and oils used for vaping marijuana, experts say. A number of the people who got sick had vaped products containing THC, the high-inducing ingredient in marijuana. CDC officials said they do not have a breakdown of how many of the sick people vaped THC. The American Vaping Association, an advocacy group, issued a statement arguing that “tainted, black market THC products” are to blame. The group called on federal officials to clear nicotine vaping products of suspicion. Matthew Myers, the head of the Campaign for Tobacco-Free Kids, said the illnesses underscore why the U.S. Food and Drug Administration should be looking into e-cigarettes and their impact on health before they can be sold to the public. Health officials said they need to gather more information. “Investigators haven’t identified any specific product or compound that is linked to all of the cases,” Ileana Arias, a CDC official who oversees non-infectious disease, said during a Friday call with reporters. She also said the sickened might be dealing with different illnesses that have similar symptoms. ___ AP Medical Writer Mike Stobbe reported from New York.

Illinois patient’s death may be first in US tied to vaping.